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The resident microbiota of the human gastrointestinal (GI) tract 
is comprised of ~2,000 bacterial species, 
the majority of which are anaerobes. 
Colonization of the GI tract is important 
for normal development of the immune 
system and provides a reservoir of cata-
bolic enzymes that degrade ingested 
plant polysaccharides. Bacteroides fragi-
lis is an important member of the micro-
biota because it contributes to T helper 
cell development, but is also the most 
frequently isolated Gram-negative anaer-
obe from clinical infections. During the 
annotation of the B. fragilis genome 
sequence, we identified a gene predicted 
to encode a homolog of the eukaryotic 
protein modifier, ubiquitin. Previously, 
ubiquitin had only been found in eukary-
otes, indicating the bacterial acquisition 
as a potential inter-kingdom horizontal 
gene transfer event. Here we discuss the 
possible roles of B. fragilis ubiquitin and 
the implications for health and disease.
Horizontal gene transfer (HGT) is a 
major driving force in the evolution of 
Eubacteria. For decades we have known 
that conjugation, transformation and 
bacteriophage-mediated transduction 
play important roles in the acquisition of 
novel functions. The advent of genomics, 
however, has illuminated the extent of 
HGT, for example, genomic comparison 
between three strains of Escherichia coli, 
the commensal K-12, enterohemorrhagic 
0157 and uropathogenic CFT073, reveals 
only 39% shared genes, with much of the 
additional DNA in these strains acquired 
horizontally.1
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Interkingdom HGT appears to occur 
less frequently, with the most studied 
being the transfer of Ti plasmid DNA 
from Agrobacterium tumefaciens to plants. 
The barriers to interkingdom transfer 
appear greater, possibly because of differ-
ences in transcription and processing of 
transcripts, e.g., splicing. Bacterial to ani-
mal HGT has been documented primarily 
where endosymbiotic organisms inhabit an 
arthropod host, with Wolbachia sp. repre-
senting the largest number of reports.2 
Transfer of DNA from the Eukaryota to 
bacteria is less evident, with relatively few 
examples, such as the eukaryotic-like pro-
teins encoded by Legionella pneumophila 
and a family of plant-like glycosyl hydro-
lases found in bacteria from the human 
gastrointestinal (GI) tract.3,4 Transfer of 
DNA from humans to bacteria, however, 
has been indicated by the presence of a 
fragment from the human long inter-
spersed nuclear element L1 in the genome 
of the host-restricted pathogen Neisseria 
gonorrhoeae.5 This suggests that a close 
association between higher eukaryotes 
and their resident microbiota might facili-
tate HGT.
The open-ended culture system of 
the human gastrointestinal tract con-
tains ~2,000 different species of bacteria. 
Within this diverse population, approxi-
mately 99% of the prokaryotic cells are 
anaerobes. The major groups of bacteria 
within the gut are represented by the phyla 
Bacteroidetes and Firmicutes.6 The Gram-
negative strictly anaerobic Bacteroides 
spp predominate, as evidenced by their 
prevalence in the product of this cul-
ture system, faeces. Bacteroides fragilis is 
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secretion system is also used by uropatho-
genic E. coli to inject the CNF1 protein 
into epithelial cells which subsequently 
deaminates Rho, Rac
GTP
 and CDC42 
and so stimulates their ubiquitination 
and destruction. Proteolysis of these 
host proteins has the dual role of activat-
ing endocytosis of the bacterial cell and 
reducing the inflammatory response.21 
Internalisation of Salmonella enterica 
typhimurium also requires modulation 
of Rac
GTP
 activity within macrophages. 
Deactivation of RacGTPase activity, by 
the Salmonella SptP protein, again leads 
to polyubiquitination and proteolysis of 
Rac which subsequently suppresses the 
inflammatory response and promotes cell 
recovery.22
B. fragilis does not encode a Type 
III secretion system, so if BfUbb inter-
acts with host proteins, how is it deliv-
ered to epithelial or other cells in the GI 
tract? Many Gram-negative bacteria pro-
duce outer membrane vesicles (OMV) 
which are released from the cell surface. 
B. fragilis produces OMV that are able 
to agglutinate red blood cells, but only if 
the OMV are coated in polysaccharides 
that represent the antigenically variable 
micro-capsule.23 BfUbb is associated with 
concentrated supernatants that contain 
OMV, suggesting that transport of the 
protein to the periplasm allows its pack-
aging and export via this route.17 OMV 
containing BfUbb could then deliver the 
cargo to epithelial cells either by mem-
brane fusion or endocytosis. Whether the 
target of OMV is epithelial cells or phago-
cytic cells, such as M-cells, expression 
of BfUbb may provide B. fragilis with a 
selective advantage for colonization of the 
mucosa by suppressing the host immune 
system or interfering with other host-cell 
functions. Additionally, the “success” 
of B. fragilis as an opportunistic patho-
gen may be partially due to a ubiquitin- 
associated ability to evade destruc-
tion if the bacterium is engulfed by a 
macrophage.
Inappropriate immune responses to 
the resident GI tract microbiota con-
tribute to inflammation of the mucosa 
and ultimately IBD. The pathways that 
recognize intracellular bacteria utilize 
receptors, such as NOD2, that bind to 
polyubiquitinated proteins, e.g., RIP2, as 
3 pseudogenes, one of which (BF3870) has 
homology to a fragment from a mobiliza-
tion protein from the relic of a potential 
conjugative transposon in B. thetaiotaomi-
cron, which reinforces the notion of hori-
zontal acquisition. Surprisingly, within 
this region is a small open reading frame 
predicted to encode a homolog of eukary-
otic ubiquitin that has 63% identity to 
human Uba52.17 The 76 amino-acid 
protein-modifier ubiquitin is highly con-
served in the Eukaryota but, until now, 
has been considered to be absent from the 
Eubacteria.18 Ubiquitin has key roles in a 
multitude of cellular processes, including 
protein degradation, cell cycle progression, 
membrane protein endocytosis, intracel-
lular trafficking, ribosome biogenesis, 
signal transduction, DNA repair, stress 
responses, chromatin-mediated regulation 
of transcription and antigen presentation.
To date, B. fragilis is unique in being 
the only bacterium to encode an identified 
ubiquitin homolog. The gene has evolved 
two additional features that differentiate 
the encoded protein from eukaryotic ubiq-
uitin: first, B. fragilis ubiquitin (BfUbb) 
contains a signal sequence that directs it 
to the periplasm; second, BfUbb has lost 
the terminal glycine residues required for 
thioester bond formation with the cata-
lytic cysteine residue in the eukaryotic E1 
activating enzyme. Other residues that are 
important for interaction with the eukary-
otic ubiquitination pathway, however, are 
conserved and BfUbb is capable of inhib-
iting the pathway in vitro.17 The presence 
of BfUbb in B. fragilis, and the additional 
features that have evolved, suggests it pro-
vides a selective advantage for the organ-
ism in the GI tract niche. This raises the 
question, “what is the function of B. fragi-
lis ubiquitin?”
It is clear that many pathogenic bacte-
ria, particularly during chronic infections, 
express virulence factors that interfere 
with ubiquitination to facilitate cell 
entry and modulate the innate immune 
response.19,20 Yersinia pestis uses a Type 
III secretion system to deliver YopJ to the 
cytoplasm of macrophages where it inhib-
its phosphorylation and subsequent ubiq-
uitination of IκB. Preventing release of 
IκB inhibits activation of the pro-inflam-
matory response and assists in develop-
ment of a systemic infection. A Type III 
medically important because it is the most 
frequently isolated obligately anaerobic 
Gram-negative bacterium from human 
clinical infections, such as intra-abdomi-
nal, vaginal, pilonidal, perianal and brain 
abscesses.7,8 B. fragilis is also a common 
cause of anaerobic bacteraemia, with a 
potential mortality of up to 30%.9
Bacterial colonisation of the mamma-
lian gut occurs after birth. The consump-
tion of breast milk by neonates provides 
oligosaccharides that are substrates for fer-
mentation by the genera Bifidobacterium 
and Bacteroides.10 The transition from 
passive immunity, associated with mater-
nal milk, to innate and adaptive immunity 
occurs concurrently with the increased 
predominance of anaerobic bacteria in the 
GI tract. The important role that com-
mensal bacteria play in ensuring correct 
development of the mammalian immune 
system is now becoming apparent, for 
example, polysaccharide A produced by 
some strains of B. fragilis alters the ratio 
of T helper cells and reduces produc-
tion of IL-17 which aids in colonization 
of the GI tract mucosa.11,12 Other resi-
dent Bacteroides also activate additional 
developmental pathways, for example, 
B. thetaiotaomicron induces fucosylation 
of intestinal epithelial cell surfaces, pro-
motes development of villus capillary 
networks and stimulates production of 
Angiogenin-4 from Paneth cells.13-15 The 
molecules responsible for modulating 
these latter effects are still unknown.
The genus Bacteroides represents 
approximately 1011 cells/g of faeces in the 
lumen of the large intestine. Despite being 
a minor constituent of the faecal micro-
biota, B. fragilis is found at high cell den-
sities in the mucosal layer adjacent to host 
epithelial cells in some individuals.16 This 
intimate association with host cells has the 
benefit of precluding invading pathogens 
from access to the gut epithelium, how-
ever, inappropriate host immune responses 
to the normal microbiota are thought to 
cause the tissue damage associated with 
inflammatory bowel disease (IBD).
During the genome sequencing of 
B. fragilis NCTC9343, we identified an 
11kb region that has a lower GC content 
compared with the backbone sequence, 
suggesting acquisition by HGT. Within 
this region there are 12 predicted genes and 
©
20
12
 L
an
de
s 
B
io
sc
ie
nc
e.
 D
o 
no
t d
is
tri
bu
te
.
www.landesbioscience.com Mobile Genetic Elements 151
17. Patrick S, Jobling KL, O’Connor D, Thacker Z, 
Dryden DTF, Blakely GW. A unique homologue of 
the eukaryotic protein-modifier ubiquitin present 
in the bacterium Bacteroides fragilis, a predomi-
nant resident of the human gastrointestinal tract. 
Microbiology 2011; 157:3071-8; PMID:21885481; 
http://dx.doi.org/10.1099/mic.0.049940-0
18. Hochstrasser M. Origin and function of ubiquitin-like 
proteins. Nature 2009; 458:422-9; PMID:19325621; 
http://dx.doi.org/10.1038/nature07958
19. Boyer L, Lemichez E. Targeting of host-cell ubiquitin 
and ubiquitin-like pathways by bacterial factors. Nat 
Rev Microbiol 2004; 2:779-88; PMID:15378042; 
http://dx.doi.org/10.1038/nrmicro1005
20. Steele-Mortimer O. Exploitation of the ubiquitin 
system by invading bacteria. Traffic 2011; 12:162-9; 
PMID:20977569; http://dx.doi.org/10.1111/j.1600-
0854.2010.01137.x
21. Doye A, Mettouchi A, Bossis G, Clément R, 
Buisson-Touati C, Flatau G, et al. CNF1 exploits 
the ubiquitin-proteasome machinery to restrict Rho 
GTPase activation for bacterial host cell invasion. 
Cell 2002; 111:553-64; PMID:12437928; http://
dx.doi.org/10.1016/S0092-8674(02)01132-7
22. Kubori T, Galán JE. Temporal regulation of sal-
monella virulence effector function by proteasome-
dependent protein degradation. Cell 2003; 115:333-
42; PMID:14636560; http://dx.doi.org/10.1016/
S0092-8674(03)00849-3
23. Patrick S, McKenna JP, O’Hagan S, Dermott E. A 
comparison of the haemagglutinating and enzymic 
activities of Bacteroides fragilis whole cells and outer 
membrane vesicles. Microb Pathog 1996; 20:191-
202; PMID:8737489; http://dx.doi.org/10.1006/
mpat.1996.0018
24. Tao M, Scacheri PC, Marinis JM, Harhaj EW, 
Matesic LE, Abbott DW. ITCH K63-ubiquitinates 
the NOD2 binding protein, RIP2, to influence 
inflammatory signaling pathways. Curr Biol 2009; 
19:1255-63; PMID:19592251; http://dx.doi.
org/10.1016/j.cub.2009.06.038
25. Hall LJ, Watson AJ. Role of autophagy in 
NOD2-induced inf lammation in Crohn’s dis-
ease. Gastroenterology 2012; 142:1032-4; 
PMID:22361060; http://dx.doi.org/10.1053/j.gas-
tro.2012.02.025
26. Zheng YT, Shahnazari S, Brech A, Lamark T, 
Johansen T, Brumell JH. The adaptor protein p62/
SQSTM1 targets invading bacteria to the autoph-
agy pathway. J Immunol 2009; 183:5909-16; 
PMID:19812211; http://dx.doi.org/10.4049/jimmu-
nol.0900441
27. Perry WL, Hustad CM, Swing DA, O’Sullivan 
TN, Jenkins NA, Copeland NG. The itchy locus 
encodes a novel ubiquitin protein ligase that is dis-
rupted in a18H mice. Nat Genet 1998; 18:143-6; 
PMID:9462742; http://dx.doi.org/10.1038/ng0298-
143
4. Arias MC, Danchin EGJ, Coutinho P, Henrissat B, 
Ball S. Eukaryote to gut bacteria transfer of a glyco-
side hydrolase gene essential for starch breakdown in 
plants. Mobile Genetic Elements 2012; in press
5. Anderson MT, Seifert HS. Opportunity and means: 
horizontal gene transfer from the human host to a 
bacterial pathogen. MBio 2011; 2:e00005-00011; 
PMID:21325040; http://dx.doi.org/10.1128/
mBio.00005-11
6. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, 
Manichanh C, et al.; MetaHIT Consortium. A 
human gut microbial gene catalogue established by 
metagenomic sequencing. Nature 2010; 464:59-
65; PMID:20203603; http://dx.doi.org/10.1038/
nature08821
7. Tally FP, Ho JL. Management of patients with 
intraabdominal infection due to colonic perfora-
tion. Curr Clin Top Infect Dis 1987; 8:266-95; 
PMID:3077280
8. Patrick S, Stewart LD, Damani N, Wilson KG, 
Lutton DA, Larkin MJ, et al. Immunological detec-
tion of Bacteroides fragilis in clinical samples. J Med 
Microbiol 1995; 43:99-109; PMID:7629860; http://
dx.doi.org/10.1099/00222615-43-2-99
9. Cheng CW, Lin HS, Ye JJ, Yang CC, Chiang PC, Wu 
TS, et al.Clinical significance of and outcomes for 
Bacteroides fragilis bacteremia. J Microbiol Immunol 
Infect 2009; 42:243-50; PMID:19812858
10. Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, 
Martens EC, Desai P, et al. Bacteroides in the infant 
gut consume milk oligosaccharides via mucus-utili-
zation pathways. Cell Host Microbe 2011; 10:507-
14; PMID:22036470; http://dx.doi.org/10.1016/j.
chom.2011.10.007
11. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 
An immunomodulatory molecule of symbiotic bac-
teria directs maturation of the host immune system. 
Cell 2005; 122:107-18; PMID:16009137; http://
dx.doi.org/10.1016/j.cell.2005.05.007
12. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila 
TA, et al. The Toll-like receptor 2 pathway establishes 
colonization by a commensal of the human micro-
biota. Science 2011; 332:974-7; PMID:21512004; 
http://dx.doi.org/10.1126/science.1206095
13. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon 
JI. A molecular sensor that allows a gut commensal 
to control its nutrient foundation in a competitive 
ecosystem. Proc Natl Acad Sci U S A 1999; 96:9833-
8; PMID:10449780; http://dx.doi.org/10.1073/
pnas.96.17.9833
14. Stappenbeck TS, Hooper LV, Gordon JI. 
Developmental regulation of intestinal angiogenesis 
by indigenous microbes via Paneth cells. Proc Natl 
Acad Sci U S A 2002; 99:15451-5; PMID:12432102; 
http://dx.doi.org/10.1073/pnas.202604299
15. Hooper LV, Stappenbeck TS, Hong CV, Gordon 
JI. Angiogenins: a new class of microbicidal pro-
teins involved in innate immunity. Nat Immunol 
2003; 4:269-73; PMID:12548285; http://dx.doi.
org/10.1038/ni888
16. Poxton IR, Brown R, Sawyerr A, Ferguson A. Mucosa-
associated bacterial f lora of the human colon. J Med 
Microbiol 1997; 46:85-91; PMID:9003751; http://
dx.doi.org/10.1099/00222615-46-1-85
scaffolds during initiation of the signaling 
cascade.24 Mutations in NOD2 are asso-
ciated with a predisposition to Crohn dis-
ease. Another allele associated with Crohn 
disease is ATG16L1, which is involved in 
intracellular clearance of invading bacte-
ria by autophagy.25 Targetting to autopha-
gosomes involves binding of autophagic 
receptors, e.g., P62, to ubiquitinated pro-
teins on the surface of intracellular bacte-
ria.26 A role for BfUbb in the genesis of 
Crohn’s disease by interfering with ubiq-
uitination of specific proteins has yet to 
be determined. Interestingly, inhibition of 
the E3 ubiquitin ligase, Itch, that ubiqui-
tinates RIP2 causes inflammatory disease 
of the large intestine in mice.27
The question remains as to the origin 
of B. fragili subb. Eukaryotic ubiquitin is 
highly conserved, however, the small num-
ber of viral genomes that encode ubiquitin 
homologs exhibit greater sequence diver-
sity. The closest nucleotide similarity to 
ubb (216 bp) is found in the genome of 
a Migratory Grasshopper (Melanoplus san-
guinipes) Entomopoxvirus (103/122 bp), 
with next closest being a Canarypox virus, 
another member of the Poxviridae. It can 
be hypothesized that the intimate asso-
ciation of B. fragilis with the human GI 
tract may have facilitated horizontal gene 
transfer from a eukaryotic virus, possibly 
associated with ingested material, to the 
B. fragilis genome.
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